首页 > 最新文献

Pneumologie最新文献

英文 中文
["Smoke-free in May 2024": concept and description of the participants]. ["2024 年 5 月无烟日":概念和参与者说明]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-12-01 Epub Date: 2024-09-25 DOI: 10.1055/a-2405-2840
Reiner Hanewinkel, Friederike Barthels, Barbara Isensee

Background: Far too many people smoke in Germany, and the number of serious attempts to stop smoking has been falling for years.

Methods: Smoke-free in May 2024 is a low-threshold measure to encourage people to stop smoking. Adults who "regularly" consume nicotine products as well as support persons were eligible to take part. As part of the measure, participants and supporters were offered daily support via app notifications, emails and/or WhatsApp. They were also made aware of existing stop-smoking programmes. Finally, prizes were raffled off among the successful participants.

Results: A total of 6,386 individuals registered to take part. Of these, 550 individuals registered with a person of their choice to support them. Smokers were predominantly female (56.5%) and on average 42.9 (SD=13.2) years old. They came from all federal states in Germany, with a disproportionately high number from the federal states of Bremen, Schleswig-Holstein, Berlin, North Rhine-Westphalia, Hamburg and Bavaria in relation to the population distribution. Compared to a representative sample from a study by the Robert Koch Institute (2012), they reported a significantly higher subjective socio-economic status. Of the participants, 79.3% categorised their addiction as high. Regular use of more than one nicotine products occurred in 35.3% of the sample; 39.8% of the participants stated that they had not tried to stop smoking during the last 12 months.

Conclusions: The number of smokers participating in the program is encouraging. In addition to an efficacy study, it should be examined in subsequent years how more males and individuals with a low subjective social status can be encouraged to initiate smoking cessation.

背景:德国有太多人吸烟,而认真尝试戒烟的人数多年来一直在下降:方法:2024 年 5 月无烟日是一项鼓励人们戒烟的低门槛措施。经常 "使用尼古丁产品的成年人以及辅助人员都有资格参加。作为该措施的一部分,参与者和支持者可通过应用程序通知、电子邮件和/或 WhatsApp 获得日常支持。他们还了解了现有的戒烟计划。最后,还在成功参与者中抽奖:结果:共有 6386 人注册参与。结果:共有 6386 人报名参加,其中 550 人与自己选择的支持者一起报名。吸烟者主要为女性(56.5%),平均年龄为 42.9 岁(SD=13.2)。他们来自德国所有联邦州,其中不莱梅、石勒苏益格-荷尔斯泰因、柏林、北莱茵-威斯特法伦州、汉堡和巴伐利亚州的吸烟者人数与人口分布不成比例。与罗伯特-科赫研究所(2012 年)研究中的代表性样本相比,他们报告的主观社会经济地位明显更高。79.3%的参与者将自己的烟瘾归类为 "高"。35.3%的参与者经常使用一种以上的尼古丁产品;39.8%的参与者表示在过去12个月中没有尝试过戒烟:结论:参与该计划的吸烟者人数令人鼓舞。结论:参与该计划的吸烟者人数令人鼓舞,除了进行疗效研究外,还应在今后几年研究如何鼓励更多男性和主观社会地位较低的人开始戒烟。
{"title":"[\"Smoke-free in May 2024\": concept and description of the participants].","authors":"Reiner Hanewinkel, Friederike Barthels, Barbara Isensee","doi":"10.1055/a-2405-2840","DOIUrl":"10.1055/a-2405-2840","url":null,"abstract":"<p><strong>Background: </strong>Far too many people smoke in Germany, and the number of serious attempts to stop smoking has been falling for years.</p><p><strong>Methods: </strong>Smoke-free in May 2024 is a low-threshold measure to encourage people to stop smoking. Adults who \"regularly\" consume nicotine products as well as support persons were eligible to take part. As part of the measure, participants and supporters were offered daily support via app notifications, emails and/or WhatsApp. They were also made aware of existing stop-smoking programmes. Finally, prizes were raffled off among the successful participants.</p><p><strong>Results: </strong>A total of 6,386 individuals registered to take part. Of these, 550 individuals registered with a person of their choice to support them. Smokers were predominantly female (56.5%) and on average 42.9 (SD=13.2) years old. They came from all federal states in Germany, with a disproportionately high number from the federal states of Bremen, Schleswig-Holstein, Berlin, North Rhine-Westphalia, Hamburg and Bavaria in relation to the population distribution. Compared to a representative sample from a study by the Robert Koch Institute (2012), they reported a significantly higher subjective socio-economic status. Of the participants, 79.3% categorised their addiction as high. Regular use of more than one nicotine products occurred in 35.3% of the sample; 39.8% of the participants stated that they had not tried to stop smoking during the last 12 months.</p><p><strong>Conclusions: </strong>The number of smokers participating in the program is encouraging. In addition to an efficacy study, it should be examined in subsequent years how more males and individuals with a low subjective social status can be encouraged to initiate smoking cessation.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"1022-1029"},"PeriodicalIF":1.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142352294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Über die Bedeutung der Allergologie für die Pneumologie.
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-12-01 Epub Date: 2024-12-13 DOI: 10.1055/a-2448-4130
Norbert Mülleneisen
{"title":"Über die Bedeutung der Allergologie für die Pneumologie.","authors":"Norbert Mülleneisen","doi":"10.1055/a-2448-4130","DOIUrl":"https://doi.org/10.1055/a-2448-4130","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":"78 12","pages":"955"},"PeriodicalIF":1.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142822533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Code of conduct for dealing with the tobacco and nicotine industry - Impulse for action for scientific societies - A consensus document by the medical societies and organizations listed below]. [与烟草和尼古丁行业打交道的行为守则--科学协会的行动动力--下列医学协会和组织的共识文件]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-12-01 Epub Date: 2024-10-29 DOI: 10.1055/a-2445-4286
{"title":"[Code of conduct for dealing with the tobacco and nicotine industry - Impulse for action for scientific societies - A consensus document by the medical societies and organizations listed below].","authors":"","doi":"10.1055/a-2445-4286","DOIUrl":"10.1055/a-2445-4286","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"958-962"},"PeriodicalIF":1.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142546861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recommendations on interpretive strategies for routine lung function tests]. [关于常规肺功能测试解释策略的建议]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-12-01 Epub Date: 2024-11-15 DOI: 10.1055/a-2437-4178
Carl-Peter Criée, Hans-Jürgen Smith, Alexandra M Preisser, Dennis Bösch, Uta Butt, Matthias M Borst, Nina Hämäläinen, Kim Husemann, Rudolf A Jörres, Peter Kardos, Christiane Lex, F Joachim Meyer, Detlev Nachtigall, Dennis Nowak, Uta Ochmann, Winfried Randerath, Ansgar Schütz, Bernd Schucher, Jens Spiesshoefer, Christian Taube, Stephan Walterspacher, Maximilian Wollsching-Strobel, Heinrich Worth, Monika Gappa, Wolfram Windisch

During the annual conference of the German Respiratory Society (DGP = Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin) in 2024, updated recommendations for lung function testing have been published. The original full-length version can be downloaded free of charge as pfd-paper from the journal entitled "Atemwegs- und Lungenkrankheiten, Jahrgang 50 (2024) März (111-184)". In the current recommendations new approaches have been embedded that focus on modern interpretations of lung function results, as has been proposed by the ERS (European Respiratory Society) in collaboration with the ATS (American Thoracic Society). This targets the spirometry, the whole bodyplethysmography, diffusion capacity testing, testing for bronchodilation, unspecific bronchoprovocation in addition to the reference values. Oscillometry and respiratory muscle function testing are also included in the recommendations. The current publication considers itself as a short version of the most important topics of the full-length lung function recommendations. However, reading also the full-length paper is strongly emphasised based on the understanding that lung function testing is highly important in daily clinical practice when dealing with patients suffering from respiratory diseases.

在 2024 年德国呼吸学会(DGP = Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin)年会期间,发布了肺功能检测的最新建议。原版全文可从题为 "Atemwegs- und Lungenkrankheiten, Jahrgang 50 (2024) März (111-184) "的期刊上以 pfd-paper 的形式免费下载。在当前的建议中,新的方法被纳入其中,其重点是对肺功能结果进行现代解释,这是由 ERS(欧洲呼吸学会)与 ATS(美国胸科学会)合作提出的。除参考值外,新方法还针对肺活量测定、全身搏动测定、弥散能力测试、支气管扩张测试、非特异性支气管定位。建议中还包括振荡计和呼吸肌功能测试。本刊物自认为是长篇肺功能建议中最重要主题的简短版本。然而,基于肺功能测试在处理呼吸系统疾病患者的日常临床实践中非常重要这一认识,我们也强烈强调阅读全文。
{"title":"[Recommendations on interpretive strategies for routine lung function tests].","authors":"Carl-Peter Criée, Hans-Jürgen Smith, Alexandra M Preisser, Dennis Bösch, Uta Butt, Matthias M Borst, Nina Hämäläinen, Kim Husemann, Rudolf A Jörres, Peter Kardos, Christiane Lex, F Joachim Meyer, Detlev Nachtigall, Dennis Nowak, Uta Ochmann, Winfried Randerath, Ansgar Schütz, Bernd Schucher, Jens Spiesshoefer, Christian Taube, Stephan Walterspacher, Maximilian Wollsching-Strobel, Heinrich Worth, Monika Gappa, Wolfram Windisch","doi":"10.1055/a-2437-4178","DOIUrl":"10.1055/a-2437-4178","url":null,"abstract":"<p><p>During the annual conference of the German Respiratory Society (DGP = Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin) in 2024, updated recommendations for lung function testing have been published. The original full-length version can be downloaded free of charge as pfd-paper from the journal entitled \"Atemwegs- und Lungenkrankheiten, Jahrgang 50 (2024) März (111-184)\". In the current recommendations new approaches have been embedded that focus on modern interpretations of lung function results, as has been proposed by the ERS (European Respiratory Society) in collaboration with the ATS (American Thoracic Society). This targets the spirometry, the whole bodyplethysmography, diffusion capacity testing, testing for bronchodilation, unspecific bronchoprovocation in addition to the reference values. Oscillometry and respiratory muscle function testing are also included in the recommendations. The current publication considers itself as a short version of the most important topics of the full-length lung function recommendations. However, reading also the full-length paper is strongly emphasised based on the understanding that lung function testing is highly important in daily clinical practice when dealing with patients suffering from respiratory diseases.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"1003-1013"},"PeriodicalIF":1.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142639567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Development of two questionnaires for the assessment of knowledge and self-management in patients with chronic-obstructive pulmonary disease (COPD)]. [用于评估慢性阻塞性肺病(COPD)患者的知识和自我管理的两种问卷的开发]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-12-01 Epub Date: 2024-04-26 DOI: 10.1055/a-2310-1887
Carolina Fischer, Rainald Fischer, Anne-Marie Kirsten, Rolf Holle, Klaus Klütsch, Cosmina Stoleriu, Ralf Göres, Konrad Schultz, Kathrin Kahnert, Peter Alter, Dennis Nowak, Rudolf Jörres

Introduction: As with other chronic diseases, the course of chronic obstructive pulmonary disease (COPD) can be expected to be positively influenced if patients are well informed about their disease and undertake appropriate self-management. Assessments of the level of knowledge and management that are comparable should benefit from structured, systematically developed questionnaires. These, however, have not been published in Germany.

Methods: A total of 310 patients with COPD were recruited from three pneumological practices and one hospital to develop the questionnaires. Based on statistical criteria and content assessments by medical specialists, two questionnaires on knowledge (17 questions) and self-management (25 questions) were developed by selecting and modifying questions from published studies and training programs. In addition, two short versions with 5 and 3 questions were created to enable a quick assessment of the patients' knowledge and self-management. All questionnaires also included a visual analogue scale for self-assessment of knowledge and self-management. The statistical procedures for systematically guided selection comprised correlation and regression analyses.

Results: The questionnaires revealed considerable knowledge deficits in many patients and remarkably unsystematic, incoherent knowledge. The extent of this knowledge was negatively correlated with higher age and positively correlated with participation in training programs; this also applied to self-management. Correlations between the answers to the knowledge questions were higher in patients who had participated in training programs. The visual analogue scales for self-assessment of knowledge and management always correlated with the total number of correct answers.

Discussion: The questionnaires on knowledge and self-management in patients with COPD could be used in outpatient settings, including by non-medical staff, in order to quickly identify and correct deficits or as a reason to recommend training programs. The short versions and the analogue scales for self-assessment can give at least first hints. Potentially, training programs should focus more on promoting the coherence of knowledge through better understanding, as this presumably favors long-term knowledge. Older patients and those with a low level of education appear to be particularly in need of specially adapted training programs.

导言:与其他慢性病一样,如果患者能够充分了解自己的疾病并进行适当的自我管理,慢性阻塞性肺病(COPD)的病程有望受到积极影响。结构化、系统化的问卷调查可以帮助评估患者的知识水平和管理水平。然而,这些问卷尚未在德国公布:方法:从三家肺科诊所和一家医院共招募了 310 名慢性阻塞性肺病患者,用于编制调查问卷。根据统计标准和医学专家的内容评估,从已发表的研究和培训项目中挑选问题并加以修改,制作了两份关于知识(17 个问题)和自我管理(25 个问题)的问卷。此外,为了快速评估患者的知识水平和自我管理能力,还制作了两份简短的问卷,分别包含 5 个问题和 3 个问题。所有问卷还包括一个视觉模拟量表,用于对知识和自我管理进行自我评估。系统指导选择的统计程序包括相关分析和回归分析:调查问卷显示,许多患者的知识相当匮乏,而且知识明显不系统、不连贯。这些知识的程度与年龄增长呈负相关,与参加培训计划呈正相关;这也适用于自我管理。参加过培训项目的患者对知识问题的回答之间的相关性更高。对知识和管理进行自我评估的视觉模拟量表始终与正确答案总数相关:讨论:慢性阻塞性肺病患者的知识和自我管理问卷可用于门诊环境,包括非医务人员,以便快速识别和纠正缺陷,或作为推荐培训项目的理由。用于自我评估的简易量表和模拟量表至少可以提供初步提示。有可能的话,培训计划应更加注重通过更好的理解来促进知识的连贯性,因为这可能有利于长期知识的积累。老年患者和教育水平较低的患者似乎尤其需要经过特别调整的培训计划。
{"title":"[Development of two questionnaires for the assessment of knowledge and self-management in patients with chronic-obstructive pulmonary disease (COPD)].","authors":"Carolina Fischer, Rainald Fischer, Anne-Marie Kirsten, Rolf Holle, Klaus Klütsch, Cosmina Stoleriu, Ralf Göres, Konrad Schultz, Kathrin Kahnert, Peter Alter, Dennis Nowak, Rudolf Jörres","doi":"10.1055/a-2310-1887","DOIUrl":"10.1055/a-2310-1887","url":null,"abstract":"<p><strong>Introduction: </strong>As with other chronic diseases, the course of chronic obstructive pulmonary disease (COPD) can be expected to be positively influenced if patients are well informed about their disease and undertake appropriate self-management. Assessments of the level of knowledge and management that are comparable should benefit from structured, systematically developed questionnaires. These, however, have not been published in Germany.</p><p><strong>Methods: </strong>A total of 310 patients with COPD were recruited from three pneumological practices and one hospital to develop the questionnaires. Based on statistical criteria and content assessments by medical specialists, two questionnaires on knowledge (17 questions) and self-management (25 questions) were developed by selecting and modifying questions from published studies and training programs. In addition, two short versions with 5 and 3 questions were created to enable a quick assessment of the patients' knowledge and self-management. All questionnaires also included a visual analogue scale for self-assessment of knowledge and self-management. The statistical procedures for systematically guided selection comprised correlation and regression analyses.</p><p><strong>Results: </strong>The questionnaires revealed considerable knowledge deficits in many patients and remarkably unsystematic, incoherent knowledge. The extent of this knowledge was negatively correlated with higher age and positively correlated with participation in training programs; this also applied to self-management. Correlations between the answers to the knowledge questions were higher in patients who had participated in training programs. The visual analogue scales for self-assessment of knowledge and management always correlated with the total number of correct answers.</p><p><strong>Discussion: </strong>The questionnaires on knowledge and self-management in patients with COPD could be used in outpatient settings, including by non-medical staff, in order to quickly identify and correct deficits or as a reason to recommend training programs. The short versions and the analogue scales for self-assessment can give at least first hints. Potentially, training programs should focus more on promoting the coherence of knowledge through better understanding, as this presumably favors long-term knowledge. Older patients and those with a low level of education appear to be particularly in need of specially adapted training programs.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"1014-1021"},"PeriodicalIF":1.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140851032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[First experience in endoscopic lung volume reduction with the FreeFlow Coil #4: A case series with three patients]. [使用 FreeFlow Coil #4 在内窥镜下缩小肺容积的首次经验:三名患者的病例系列]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-12-01 Epub Date: 2024-08-15 DOI: 10.1055/a-2368-5046
Paul Ferdinand Fiedler, Karl-Josef Franke

Lung volume reduction therapy is an established treatment for patients with severe emphysema of the lung. In Germany, the treatment with nitinol coils is the only method for endoscopic lung volume reduction in patients with positive collateral ventilation approved by the Gemeinsamer Bundesausschuss. Therefore this procedure can be performed as standard-of-care and has assured reimbursement. After the production of the initial coils was stopped for years, when the only manufacturer had been bought by a large corporation, by the end of 2022 there was a new nitinol-coil, the so called Coil #4, becme available in the European market. The new Coil #4 has a different shape, different application catheter and the implantation procedure differs from that of the original product. We report our experience in endoscopic lung volume reduction with the new Coil #4 in three patients with emphysema. The procedure was performed without complications. All three of them showed improvement in lung function parameters meeting minimal clinically important differences. In two of three patients, we also saw clinically relevant improvement in the 6MWT distance und improvements in SGRQ und CAT-Score. In our opinion, this case series is just a prospect of the possibilities that come with the Coil #4. With due caution, we will continue to offer the Coil #4 as a treatment for selected patients under constant evaluation of the outcome until more data is available.

肺容积缩小疗法是一种治疗严重肺气肿患者的成熟疗法。在德国,使用镍钛诺线圈治疗是内窥镜肺容积缩小术治疗正侧向通气患者的唯一方法,已获得德国联邦卫生部批准。因此,这种治疗方法可作为标准治疗方法进行,并可确保报销。最初的线圈停产多年后,唯一的制造商被一家大公司收购,到 2022 年底,欧洲市场上出现了一种新的镍钛诺线圈,即所谓的 4 号线圈。新的 4 号线圈具有不同的形状、不同的应用导管,植入过程也与原产品不同。我们报告了使用新型 4 号线圈在三名肺气肿患者身上进行内窥镜肺容积缩小术的经验。手术过程无并发症。三位患者的肺功能指标均有改善,达到了最小临床意义差异。在三名患者中,有两名患者的 6MWT 距离有了临床意义上的改善,SGRQ 和 CAT 评分也有所提高。我们认为,这组病例只是对 4 号线圈可能性的一个展望。在获得更多数据之前,我们将继续谨慎地为特定患者提供 4 号线圈治疗,并不断评估治疗效果。
{"title":"[First experience in endoscopic lung volume reduction with the FreeFlow Coil #4: A case series with three patients].","authors":"Paul Ferdinand Fiedler, Karl-Josef Franke","doi":"10.1055/a-2368-5046","DOIUrl":"10.1055/a-2368-5046","url":null,"abstract":"<p><p>Lung volume reduction therapy is an established treatment for patients with severe emphysema of the lung. In Germany, the treatment with nitinol coils is the only method for endoscopic lung volume reduction in patients with positive collateral ventilation approved by the Gemeinsamer Bundesausschuss. Therefore this procedure can be performed as standard-of-care and has assured reimbursement. After the production of the initial coils was stopped for years, when the only manufacturer had been bought by a large corporation, by the end of 2022 there was a new nitinol-coil, the so called Coil #4, becme available in the European market. The new Coil #4 has a different shape, different application catheter and the implantation procedure differs from that of the original product. We report our experience in endoscopic lung volume reduction with the new Coil #4 in three patients with emphysema. The procedure was performed without complications. All three of them showed improvement in lung function parameters meeting minimal clinically important differences. In two of three patients, we also saw clinically relevant improvement in the 6MWT distance und improvements in SGRQ und CAT-Score. In our opinion, this case series is just a prospect of the possibilities that come with the Coil #4. With due caution, we will continue to offer the Coil #4 as a treatment for selected patients under constant evaluation of the outcome until more data is available.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"1030-1034"},"PeriodicalIF":1.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Diagnosis and Treatment of Hypersensitivity Pneumonitis - S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology]. [过敏性肺炎的诊断与治疗--德国呼吸学会和德国过敏学与临床免疫学学会 S2k 指南]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-12-01 Epub Date: 2024-09-03 DOI: 10.1055/a-2369-8458
Dirk Koschel, Jürgen Behr, Melanie Berger, Francesco Bonella, Okka Hamer, Marcus Joest, Danny Jonigk, Michael Kreuter, Gabriela Leuschner, Dennis Nowak, Monika Raulf, Beate Rehbock, Jens Schreiber, Helmut Sitter, Dirk Theegarten, Ulrich Costabel

Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease (ILD) in sensitized individuals caused by a large variety of inhaled antigens. The clinical form of acute HP is often misdiagnosed, while the chronic form, especially the chronic fibrotic HP, is difficult to differentiate from other fibrotic ILDs. The present guideline for the diagnosis and treatment of HP replaces the former German recommendations for the diagnosis of HP from 2007 and is amended explicitly by the issue of the chronic fibrotic form, as well as by treatment recommendations for the first time. The evidence was discussed by a multidisciplinary committee of experts. Then, recommendations were formulated for twelve questions on important issues of diagnosis and treatment strategies. Recently published national and international guidelines for ILDs and HP were considered. Detailed background information on HP is useful for a deeper insight into HP and the handling of the guideline.

过敏性肺炎(HP)是由多种吸入性抗原引起的免疫介导的间质性肺疾病(ILD)。临床上,急性过敏性肺炎经常被误诊,而慢性过敏性肺炎,尤其是慢性纤维化过敏性肺炎,则很难与其他纤维化 ILD 区分开来。目前的 HP 诊断和治疗指南取代了德国自 2007 年起提出的 HP 诊断建议,并对慢性纤维化型 HP 的问题进行了明确修订,还首次提出了治疗建议。多学科专家委员会对证据进行了讨论。然后,针对诊断和治疗策略方面的 12 个重要问题提出了建议。同时还考虑了最近发布的关于 ILD 和 HP 的国家和国际指南。有关 HP 的详细背景信息有助于深入了解 HP 和处理该指南。
{"title":"[Diagnosis and Treatment of Hypersensitivity Pneumonitis - S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology].","authors":"Dirk Koschel, Jürgen Behr, Melanie Berger, Francesco Bonella, Okka Hamer, Marcus Joest, Danny Jonigk, Michael Kreuter, Gabriela Leuschner, Dennis Nowak, Monika Raulf, Beate Rehbock, Jens Schreiber, Helmut Sitter, Dirk Theegarten, Ulrich Costabel","doi":"10.1055/a-2369-8458","DOIUrl":"10.1055/a-2369-8458","url":null,"abstract":"<p><p>Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease (ILD) in sensitized individuals caused by a large variety of inhaled antigens. The clinical form of acute HP is often misdiagnosed, while the chronic form, especially the chronic fibrotic HP, is difficult to differentiate from other fibrotic ILDs. The present guideline for the diagnosis and treatment of HP replaces the former German recommendations for the diagnosis of HP from 2007 and is amended explicitly by the issue of the chronic fibrotic form, as well as by treatment recommendations for the first time. The evidence was discussed by a multidisciplinary committee of experts. Then, recommendations were formulated for twelve questions on important issues of diagnosis and treatment strategies. Recently published national and international guidelines for ILDs and HP were considered. Detailed background information on HP is useful for a deeper insight into HP and the handling of the guideline.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"963-1002"},"PeriodicalIF":1.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sekretolyse – mögliche Vorgehensweisen. 分泌溶解--可能的程序。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-11-18 DOI: 10.1055/a-1935-2240
Thomas Hillmann
{"title":"Sekretolyse – mögliche Vorgehensweisen.","authors":"Thomas Hillmann","doi":"10.1055/a-1935-2240","DOIUrl":"10.1055/a-1935-2240","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Maternity protection in pneumology: considerations for a positive list]. [肺病学中的产妇保护:正面清单的考虑因素]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-11-07 DOI: 10.1055/a-2438-0418
Christine Ganzert, Sabine Darius, Irina Böckelmann

It seems difficult to continue to employ expectant/breastfeeding mothers in interventional medical fields due to numerous risks involved, such as in handling infectious agents or anaesthetic gases. Pregnancy for female doctors is thus often associated with a ban on employment and is therefore synonymous with a delay in their professional career. The aim of this article was to develop a positive list that allows pregnant women to continue working during their pregnancy at low risk and provides employers with a guide for drawing up risk assessment for specific occasions. The brief narrative overview is based on the recommendations drawn up by both professional associations and the Maternity Protection Committee. It is intended to provide assistance for the preparation of an event-related risk assessment after notification of a pregnancy in the speciality of pneumology in order to be able to continue to employ female doctors working in interventional medicine at low risk.

在介入性医疗领域,似乎很难继续雇用待产/哺乳期的母亲,因为这涉及到许多风险,如处理传染性病原体或麻醉气体。因此,女医生怀孕往往与禁止就业联系在一起,并因此成为职业生涯延迟的代名词。本文旨在制定一份积极的清单,允许孕妇在怀孕期间以较低的风险继续工作,并为雇主提供一份针对特定场合的风险评估指南。简短的叙述性概述以专业协会和孕产妇保护委员会起草的建议为基础。其目的是帮助气动专业的女医生在通知怀孕后准备与事件相关的风险评估,以便能够继续低风险地雇用从事介入医学工作的女医生。
{"title":"[Maternity protection in pneumology: considerations for a positive list].","authors":"Christine Ganzert, Sabine Darius, Irina Böckelmann","doi":"10.1055/a-2438-0418","DOIUrl":"https://doi.org/10.1055/a-2438-0418","url":null,"abstract":"<p><p>It seems difficult to continue to employ expectant/breastfeeding mothers in interventional medical fields due to numerous risks involved, such as in handling infectious agents or anaesthetic gases. Pregnancy for female doctors is thus often associated with a ban on employment and is therefore synonymous with a delay in their professional career. The aim of this article was to develop a positive list that allows pregnant women to continue working during their pregnancy at low risk and provides employers with a guide for drawing up risk assessment for specific occasions. The brief narrative overview is based on the recommendations drawn up by both professional associations and the Maternity Protection Committee. It is intended to provide assistance for the preparation of an event-related risk assessment after notification of a pregnancy in the speciality of pneumology in order to be able to continue to employ female doctors working in interventional medicine at low risk.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antwort zu „Ist die VATS tatsächlich der Goldstandard in der Diagnostik des malignen Mesothelioms?“. 回答 "VATS 真的是诊断恶性间皮瘤的金标准吗?
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-11-01 Epub Date: 2024-11-08 DOI: 10.1055/a-2430-0683
Lea van der Linde, Lutz Welker
{"title":"Antwort zu „Ist die VATS tatsächlich der Goldstandard in der Diagnostik des malignen Mesothelioms?“.","authors":"Lea van der Linde, Lutz Welker","doi":"10.1055/a-2430-0683","DOIUrl":"https://doi.org/10.1055/a-2430-0683","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":"78 11","pages":"830"},"PeriodicalIF":1.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pneumologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1